早发性肥胖:GNAS突变和甲基化改变未被识别的首个证据
该研究在早发性肥胖患儿中发现,重度肥胖可为PHP1B或PHP1A的首个临床表现。5例婴儿因STX16缺失和/或GNAS甲基化异常确诊PHP1B;24例未选择的肥胖患者中2例发现遗传性STX16缺失;5例初期无Albright遗传性骨营养不良特征的患儿因GNAS突变确诊PHP1A。
要点
- 重度早发性肥胖可为PHP1B的首个临床证据,扩展了PHP1A与PHP1B的表型重叠谱。
- GNAS甲基化异常无法被靶向或全基因组测序策略检出,提示对不明原因肥胖可考虑表观遗传学GNAS分析。
- 24例未选择的肥胖患者中2例发现遗传性STX16缺失。
核心结论
- 生命第一年的肥胖可为PHP1B的首个临床证据,扩展了PHP1A与PHP1B之间的表型重叠谱。
- GNAS甲基化异常无法被靶向或全基因组测序策略检出,这提出了对不明原因肥胖是否应考虑表观遗传学GNAS分析的问题。
研究设计与样本
- 在早发性肥胖患者队列中搜索GNAS甲基化改变或突变。
- 对24例未选择的肥胖患者进行分析。
主要发现
- 5例婴儿被观察到重度肥胖,后因STX16缺失和/或GNAS甲基化异常诊断为PHP1B。
- 24例未选择的肥胖患者中2例发现遗传性STX16缺失。
- 5例患者初期缺乏Albright遗传性骨营养不良的额外特征,后因涉及编码Gsα外显子的GNAS突变诊断为PHP1A,这些患者早期体重增长显著。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Early-onset obesity, characteristic for disorders affecting the leptin-melanocortin pathway, is also observed in pseudohypoparathyroidism type 1A (PHP1A), a disorder caused by maternal GNAS mutations that disrupt expression or function of the stimulatory G protein α-subunit (Gsα). Mutations and/or epigenetic abnormalities at the same genetic locus are also the cause of pseudohypoparathyroidism type 1B (PHP1B). However, although equivalent biochemical and radiographic findings can be encountered in these related disorders caused by GNAS abnormalities, they are considered distinct clinical entities. OBJECTIVES: To further emphasize the overlapping features between both disorders, we report the cases of several children, initially brought to medical attention because of unexplained early-onset obesity, in whom PHP1B or PHP1A was eventually diagnosed. PATIENTS AND METHODS: Search for GNAS methylation changes or mutations in cohorts of patients with early-onset obesity. RESULTS: Severe obesity had been noted in five infants, with a later diagnosis of PHP1B due to STX16 deletions and/or abnormal GNAS methylation. These findings prompted analysis of 24 unselected obese patients, leading to the discovery of inherited STX16 deletions in 2 individuals. Similarly, impressive early weight gains were noted in five patients, who initially lacked additional Albright hereditary osteodystrophy features but in whom PHP1A due to GNAS mutations involving exons encoding Gsα was diagnosed. CONCLUSIONS: Obesity during the first year of life can be the first clinical evidence for PHP1B, expanding the spectrum of phenotypic overlap between PHP1A and PHP1B. Importantly, GNAS methylation abnormalities escape detection by targeted or genome-wide sequencing strategies, raising the question of whether epigenetic GNAS analyses should be considered for unexplained obesity.
引用
- Grüters-Kieslich A, Reyes M, Sharma A, et al. Early-Onset Obesity: Unrecognized First Evidence for GNAS Mutations and Methylation Changes. J Clin Endocrinol Metab. 2017. PMID: 28453643. doi:10.1210/jc.2017-00395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。